COMPOSITIONS FOR GENE TRANSFER TO THE CENTRAL NERVOUS SYSTEM

(19)

(11)

EP 0 927 043 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	18.04.2007 Bulletin 2007/16

(45)	Mention of the grant of the patent:
	13.12.2006 Bulletin 2006/50

(21)	Application number: 97920192.8

(22)	Date of filing: 07.04.1997

(51)

International Patent Classification (IPC):

A61K 39/00^(2006.01)

A61K 48/00^(2006.01)

(86)	International application number:
	PCT/US1997/005746

(87)	International publication number:
	WO 1997/037684 (16.10.1997 Gazette 1997/44)

(54)	COMPOSITIONS FOR GENE TRANSFER TO THE CENTRAL NERVOUS SYSTEM ZUSAMMENSETZUNGEN ZUR GENTRANSFER IN DAS ZENTRALE NERVENSYSTEM COMPOSITIONS POUR LE TRANSFERT D'UN GENE DANS LE SYSTEME NERVEUX CENTRAL

(84)	Designated Contracting States:
	AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

08.04.1996 US 629308

(43)	Date of publication of application:
	07.07.1999 Bulletin 1999/27

(73)	Proprietors:
	NEW YORK UNIVERSITY New York, NY 10016 (US) TITAN PHARMACEUTICALS, INC. Somerville, NJ 08876 (US)

(72)	Inventors:
	CHERSKEY, Bruce Hoboken, NJ 07030 (US) BUCALO, Louis, R. San Francisco, CA 94123 (US)

(74)	Representative: Roques, Sarah Elizabeth
	J.A. Kemp & Co. 14 South Square Gray's Inn London WC1R 5JJ London WC1R 5JJ (GB)

(56)

References cited: :

WO-A-89/02468
WO-A-93/04167
WO-A-94/24298

WO-A-92/06702
WO-A-93/14790

PEAR WARREN S ET AL: "Production of high-titer helper-free retroviruses by transient transfection" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 90, no. 18, 1993, pages 8392-8396, XP002286628 ISSN: 0027-8424
PROC. NATL. ACAD. SCI. U.S.A., September 1993, Vol. 90, PEAR et al., "Production of High-Titer Helper-Free Retroviruses by Transient Transfection", pages 8392-8396.
TIG, May 1994, Vol. 10, No. 5, CULVER et al., "Gene Therapy for Cancer", pages 174-178.

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).